Department of Orthopaedics, Shanghai Bone Tumor Institute, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road Shanghai, Shanghai, China.
Stem Cell Res Ther. 2018 Jan 31;9(1):22. doi: 10.1186/s13287-018-0780-x.
During tumorigenesis and development, participation of the tumor microenvironment is not negligible. As an important component in the tumor microenvironment, mesenchymal stem cells (MSCs) have been corroborated to mediate proliferation, metastasis, and drug resistance in many cancers, including osteosarcoma. What's more, because of tumor site tropism, MSCs can be engineered to be loaded with therapeutic agents so that drugs can be precisely delivered to tumor lesions. In this review, we mainly discuss recent advances concerning the functions of MSCs in osteosarcoma and their possible clinical applications in the future.
在肿瘤发生和发展过程中,肿瘤微环境的参与不可忽视。作为肿瘤微环境的重要组成部分,间充质干细胞(MSCs)已被证实可介导多种癌症(包括骨肉瘤)的增殖、转移和耐药性。更重要的是,由于肿瘤部位的趋向性,MSCs 可以被工程化以装载治疗剂,从而使药物能够精确递送到肿瘤病变部位。在这篇综述中,我们主要讨论了 MSCs 在骨肉瘤中的功能的最新进展及其在未来可能的临床应用。